Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kea Franz

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
European Journal of Nutrition|September 6, 2021
Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trialMartin Voss, Katharina J Wenger, Nina von Mettenheim, et al.
Journal of Neuro-Oncology|May 20, 2016
Prognostic factors in recurrent glioblastoma patients treated with bevacizumabChristina Schaub, Julia Tichy, Niklas Schäfer, et al.
Neuro-Oncology|December 3, 2015
Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomasPeter Baumgarten, Anna-Eva Blank, Kea Franz, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2020
ERGO2: A Prospective, Randomized Trial of Calorie-Restricted Ketogenic Diet and Fasting in Addition to Reirradiation for Malignant GliomaMartin Voss, Marlies Wagner, Nina von Mettenheim, et al.
Journal of Neuro-Oncology|July 21, 2022
Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysisAnna-Luisa Luger, Sven König, Patrick Felix Samp, et al.
Brain Pathology (Zurich, Switzerland)|December 4, 2018
Distribution and prognostic impact of microglia/macrophage subpopulations in gliomasPia S Zeiner, Corinna Preusse, Anna Golebiewska, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
European Journal of Nutrition|September 6, 2021
Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trialMartin Voss, Katharina J Wenger, Nina von Mettenheim, et al.
Journal of Neuro-Oncology|May 20, 2016
Prognostic factors in recurrent glioblastoma patients treated with bevacizumabChristina Schaub, Julia Tichy, Niklas Schäfer, et al.
Neuro-Oncology|December 3, 2015
Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomasPeter Baumgarten, Anna-Eva Blank, Kea Franz, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2020
ERGO2: A Prospective, Randomized Trial of Calorie-Restricted Ketogenic Diet and Fasting in Addition to Reirradiation for Malignant GliomaMartin Voss, Marlies Wagner, Nina von Mettenheim, et al.
Journal of Neuro-Oncology|July 21, 2022
Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysisAnna-Luisa Luger, Sven König, Patrick Felix Samp, et al.
Brain Pathology (Zurich, Switzerland)|December 4, 2018
Distribution and prognostic impact of microglia/macrophage subpopulations in gliomasPia S Zeiner, Corinna Preusse, Anna Golebiewska, et al.
Pageof 7